Biomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER21 gastric adenocarcinoma (GEA)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Catenacci, DVT; Park, H; Uronis, HE; Kang, Y-K; Ng, M; Gold, P; Lacy, J; Enzinger, PC; Park, S; Lee, K-W; Yen, J; Odegaard, J; Franovic, A; Baughman, J; Muth, J; Wynter-Horton, A; Wu, T; Wigginton, J; Davidson-Moncada, JK; Bang, Y-J

Published Date

  • October 1, 2018

Published In

Volume / Issue

  • 29 /

Start / End Page

  • 223 - 223

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 43rd ESMO Congress (ESMO)

Conference Location

  • Munich, GERMANY

Conference Start Date

  • October 19, 2018

Conference End Date

  • October 23, 2018